Primary pigmented nodular adrenocortical disease: a case report in a 7-year-old girl

Abstract Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of Cushing syndrome in children, often occurring in association with Carney complex. We report a case of Cushing syndrome due to isolated non-familial PPNAD. The child presented with typical clinical characteristics, growth retardation and obesity. Liddle’s test was positive but micronodular appearance was not evident on CT scan and MRI; selective venous sampling revealed higher cortisol concentrations in the right adrenal vein. The patient underwent a laparoscopic right adrenalectomy. Postoperatively, hypercortisolism signs disappeared but after the second year a slight increase in urinary cortisol was noted and the patient developed osteopenia. Although significant catch-up growth occurred postoperatively, height did not normalize over the next 2 years. When she entered puberty, treatment with a luteinizing-hormone-releasing hormone agonist was initiated and growth hormone was added. Almost 5 years later a left adrenalectomy was also performed. Thereafter, complete disease remission was observed, the patient’s growth accelerated and her osteopenia reversed.

[1]  C. Stratakis,et al.  Unraveling the molecular basis of micronodular adrenal hyperplasia , 2008, Current opinion in endocrinology, diabetes, and obesity.

[2]  S. Steinberg,et al.  Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. , 2008, Surgery.

[3]  I. Bossis,et al.  Phosphodiesterase 11A Expression in the Adrenal Cortex, Primary Pigmented Nodular Adrenocortical Disease, and other Corticotropin-independent Lesions , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  H. Storr,et al.  Pediatric Cushing's syndrome: clinical features, diagnosis, and treatment. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[5]  K. Kayasut,et al.  Primary pigmented nodular adrenocortical disease with synaptophysin immunoreactivity in two thai children. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[6]  Stratakis Ca.  Adrenocortical Tumors, Primary Pigmented Adrenocortical Disease (PPNAD)/Carney Complex, and other Bilateral Hyperplasias: The NIH Studies , 2007 .

[7]  P. Gregersen,et al.  Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. , 2006, Cancer research.

[8]  I. Bossis,et al.  A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia , 2006, Nature Genetics.

[9]  P. Chanson,et al.  A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. , 2006, The Journal of clinical endocrinology and metabolism.

[10]  C. Stratakis,et al.  Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? , 2004, The Journal of clinical endocrinology and metabolism.

[11]  C. Bhagat.  Diagnosis and Complications of Cushing's Syndrome: a Consensus Statement. , 2004 .

[12]  J. Bertherat,et al.  Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. , 2003, Cancer research.

[13]  W. Schürch,et al.  Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  J. Bertherat,et al.  Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. , 2002, The Journal of clinical endocrinology and metabolism.

[15]  C. Stratakis,et al.  Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  D. Papanicolaou,et al.  Paradoxical Response to Dexamethasone in the Diagnosis of Primary Pigmented Nodular Adrenocortical Disease , 1999, Annals of Internal Medicine.

[17]  N. Stylopoulos,et al.  How accurate is computed tomography in predicting the real size of adrenal tumors? A retrospective study. , 1997, Archives of surgery.

[18]  J. Doppman,et al.  Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  C. Shin,et al.  Cushing Syndrome in Children and Adolescents , 1995 .

[20]  J. Doppman,et al.  Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. , 1994, The New England journal of medicine.

[21]  W. Travis,et al.  Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. , 1989, Radiology.

[22]  Carney Ja,et al.  Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. , 1984 .

[23]  R. Bahn,et al.  Primary adrenocortical nodular dysplasia as a cause of Cushing's syndrome in infants and children. , 1982, Mayo Clinic proceedings.